Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 391

1.

Targeting the Plasmodium vivax Duffy-binding protein.

Chitnis CE, Sharma A.

Trends Parasitol. 2008 Jan;24(1):29-34. Epub 2007 Nov 26. Review.

PMID:
18023618
[PubMed - indexed for MEDLINE]
2.

Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.

Singh AP, Puri SK, Chitnis CE.

Mol Biochem Parasitol. 2002 Apr 30;121(1):21-31.

PMID:
11985860
[PubMed - indexed for MEDLINE]
3.

Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion.

Hans D, Pattnaik P, Bhattacharyya A, Shakri AR, Yazdani SS, Sharma M, Choe H, Farzan M, Chitnis CE.

Mol Microbiol. 2005 Mar;55(5):1423-34.

PMID:
15720551
[PubMed - indexed for MEDLINE]
4.

Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).

Choe H, Moore MJ, Owens CM, Wright PL, Vasilieva N, Li W, Singh AP, Shakri R, Chitnis CE, Farzan M.

Mol Microbiol. 2005 Mar;55(5):1413-22.

PMID:
15720550
[PubMed - indexed for MEDLINE]
5.

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.

Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, Cui L, Bockarie M, Chitnis C, Adams J, Zimmerman PA, King CL.

PLoS Med. 2007 Dec;4(12):e337.

PMID:
18092885
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.

Singh S, Pandey K, Chattopadhayay R, Yazdani SS, Lynn A, Bharadwaj A, Ranjan A, Chitnis C.

J Biol Chem. 2001 May 18;276(20):17111-6. Epub 2001 Mar 13.

PMID:
11279211
[PubMed - indexed for MEDLINE]
Free Article
7.

Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.

Arévalo-Herrera M, Castellanos A, Yazdani SS, Shakri AR, Chitnis CE, Dominik R, Herrera S.

Am J Trop Med Hyg. 2005 Nov;73(5 Suppl):25-31.

PMID:
16291763
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.

Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH.

J Exp Med. 1996 Oct 1;184(4):1531-6.

PMID:
8879225
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Towards a vaccine against Plasmodium vivax malaria.

Beeson JG, Crabb BS.

PLoS Med. 2007 Dec;4(12):e350. No abstract available.

PMID:
18092888
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins.

Ranjan A, Chitnis CE.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14067-72.

PMID:
10570199
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The domain on the mouse Duffy protein for Plasmodium yoelii binding and invasion to mouse erythrocytes.

Xu L, Niu J, Chaudhuri A.

Mol Biochem Parasitol. 2006 Apr;146(2):142-50. Epub 2005 Dec 13.

PMID:
16386320
[PubMed - indexed for MEDLINE]
13.

Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes.

Siddiqui AA, Xainli J, Schloegel J, Carias L, Ntumngia F, Shoham M, Casey JL, Foley M, Adams JH, King CL.

Infect Immun. 2012 Aug;80(8):2920-8. doi: 10.1128/IAI.00206-12. Epub 2012 May 21.

PMID:
22615246
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites.

Michon P, Stevens JR, Kaneko O, Adams JH.

Mol Biol Evol. 2002 Jul;19(7):1128-42.

PMID:
12082132
[PubMed - indexed for MEDLINE]
Free Article
15.

Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.

Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS.

Vaccine. 2007 Jul 9;25(28):5166-74. Epub 2007 May 21.

PMID:
17544179
[PubMed - indexed for MEDLINE]
16.

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, Cole-Tobian JL, Mueller I, Chitnis CE.

Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8363-8. doi: 10.1073/pnas.0800371105. Epub 2008 Jun 3.

PMID:
18523022
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor.

Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH.

Science. 1993 Aug 27;261(5125):1182-4.

PMID:
7689250
[PubMed - indexed for MEDLINE]
18.

Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.

Yazdani SS, Shakri AR, Mukherjee P, Baniwal SK, Chitnis CE.

Vaccine. 2004 Sep 9;22(27-28):3727-37.

PMID:
15315853
[PubMed - indexed for MEDLINE]
19.

Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria.

King CL, Adams JH, Xianli J, Grimberg BT, McHenry AM, Greenberg LJ, Siddiqui A, Howes RE, da Silva-Nunes M, Ferreira MU, Zimmerman PA.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20113-8. doi: 10.1073/pnas.1109621108. Epub 2011 Nov 28.

PMID:
22123959
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Maestre A, Muskus C, Duque V, Agudelo O, Liu P, Takagi A, Ntumngia FB, Adams JH, Sim KL, Hoffman SL, Corradin G, Velez ID, Wang R.

PLoS One. 2010 Jul 15;5(7):e11437. doi: 10.1371/journal.pone.0011437.

PMID:
20664684
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk